We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
-22.67%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
AUM
$158M
AUM Growth
-$88.2M
Cap. Flow
-$18.2M
Cap. Flow %
-11.49%
Top 10 Hldgs %
61.01%
Holding
131
New
17
Increased
16
Reduced
19
Closed
9

Sector Composition

1 Healthcare 37.68%
2 Financials 16.27%
3 Industrials 8.33%
4 Technology 7.76%
5 Communication Services 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGND icon
1
Ligand Pharmaceuticals
LGND
$5.94B
$25.7M 16.2%
565,925
SRCL
2
DELISTED
Stericycle Inc
SRCL
$13.1M 8.25%
269,083
APO icon
3
Apollo Global Management
APO
$71.1B
$12.5M 7.88%
372,500
+135,000
+57% +$5.8M
UPLD icon
4
Upland Software
UPLD
$15.6M
$11.1M 6.99%
41,300
-2,500
-6% -$904K
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.32T
$9.19M 5.8%
158,000
KKR icon
6
KKR & Co
KKR
$92.3B
$4.81M 3.04%
+205,000
New +$5.89M
FSK icon
7
FS KKR Capital
FSK
$3.11B
$4.74M 2.99%
395,175
+13,425
+4% +$287K
PFE icon
8
Pfizer
PFE
$143B
$4.31M 2.72%
139,023
CCXI
9
DELISTED
ChemoCentryx, Inc.
CCXI
$4.04M 2.55%
100,431
-5,644
-5% -$240K
BRSL
10
Brightstar Lottery PLC
BRSL
$2.02B
$3.62M 2.28%
607,500
LKQ icon
11
LKQ Corp
LKQ
$6.63B
$3.08M 1.94%
150,000
-50,000
-25% -$1.48M
ABBV icon
12
AbbVie
ABBV
$449B
$2.68M 1.69%
35,233
+2,280
+7% +$194K
BMY icon
13
Bristol-Myers Squibb
BMY
$124B
$2.56M 1.62%
45,909
+2,194
+5% +$134K
BLU
14
DELISTED
BELLUS Health Inc.
BLU
$2.42M 1.53%
242,611
FNM.PRT
15
DELISTED
FEDERAL NATL MTG ASS 08250
FNM.PRT
$2.19M 1.38%
396,736
+250,000
+170% +$1.38M
CLMT icon
16
Calumet Specialty Products
CLMT
$3.58B
$2.12M 1.34%
2,020,000
JPM icon
17
JPMorgan Chase
JPM
$912B
$2.08M 1.31%
23,050
XENE icon
18
Xenon Pharmaceuticals
XENE
$6.47B
$1.99M 1.25%
175,204
-20,453
-10% -$291K
BDSI
19
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.92M 1.21%
505,530
+923
+0.2% +$4.54K
EIGR
20
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.79M 1.13%
8,792
+977
+13% +$311K
HZNP
21
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.76M 1.11%
59,531
-1,325
-2% -$44.8K
KDMN
22
DELISTED
Kadmon Holdings, Inc.
KDMN
$1.6M 1.01%
381,900
+106,900
+39% +$460K
ZGNX
23
DELISTED
Zogenix, Inc.
ZGNX
$1.3M 0.82%
+52,765
New +$1.92M
FNM.PRP
24
DELISTED
Federal National Mortgage Association Non Cum Pfd Ser P
FNM.PRP
$1.17M 0.74%
254,559
MPLX icon
25
MPLX
MPLX
$58B
$1.16M 0.73%
100,000
-266,558
-73% -$5.46M

Similar funds

David M. Knott's Q1 2020 Portfolio in Review

As of Q1 2020, David M. Knott held 131 positions worth $158M, down 36% from $247M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

David M. Knott withdrew a net $18.2M in Q1 2020, closing 9 positions and reducing 19 holdings. Its most notable exit was FTAI Aviation, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.

Against the trend, David M. Knott opened a new position in KKR & Co worth $4.81M.

  • David M. Knott's largest Q1 2020 buy was KKR & Co: 205,000 shares worth $4.81M.
  • David M. Knott added most to Apollo Global Management in Q1 2020, an estimated $5.8M increase.
  • David M. Knott's biggest Q1 2020 reduction was Macquarie Infrastructure Holdings, LLC, cutting an estimated $6.23M.
  • David M. Knott fully exited FTAI Aviation in Q1 2020, selling an estimated $17.4M.
  • David M. Knott's ten largest holdings make up 61% of its $158M portfolio in Q1 2020.
  • David M. Knott opened 17 new positions and closed 9 in Q1 2020.
  • David M. Knott's portfolio value fell 36% quarter-over-quarter to $158M.

Based on David M. Knott's 13F filing for Q1 2020, filed 13 May 2020.